Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value

Lin GA, Whittington MD, Nikitin D, Agboola F, McKenna A, Herron-Smith S, Pearson SD, Campbell J
Record ID 32018005194
Project Status: Completed
Year Published: 2023
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Cost-Effectiveness Analysis
  • Antibodies, Monoclonal
  • Sphingosine 1 Phosphate Receptor Modulators
  • Fingolimod Hydrochloride
  • Fumarates
  • Natalizumab
  • Rituximab
Organisation Name: Institute for Clinical and Economic Review
Contact Address: 101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name: info@icer-review.org
Contact Email: info@icer-review.org
Copyright: <p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.